Literature DB >> 11068074

Update in internal medicine.

F López-Jiménez1, M Brito, Y W Aude, P Scheinberg, M Kaplan, D A Dixon, N Schneiderman, J F Trejo, L H López-Salazar, E J Ramírez-Barba, R Kalil, C Ortiz, J Goyos, A Buenaño, S Kottiech, G A Lamas.   

Abstract

More than 500,000 new medical articles are published every year and available time to keep updated is scarcer every day. Nowadays, the task of selecting useful, consistent, and relevant information for clinicians is a priority in many major medical journals. This review has the aim of gathering the results of the most important findings in clinical medicine in the last few years. It is focused on results from randomized clinical trials and well-designed observational research. Findings were included preferentially if they showed solid results, and we avoided as much as possible including only preliminary data, or results that included only non-clinical outcomes. Some of the most relevant findings reported here include the significant benefit of statins in patients with coronary artery disease even with mean cholesterol level. It also provides a substantial review of the most significant trials assessing the effectiveness of IIb/IIIa receptor blockers. In gastroenterology many advances have been made in the H. pylori eradication, and the finding that the cure of H. pylori infection may be followed by gastroesophageal reflux disease. Some new antivirals have shown encouraging results in patients with chronic hepatitis. In the infectious disease arena, the late breaking trials in anti-retroviral disease are discussed, as well as the new trends regarding antibiotic resistance. This review approaches also the role of leukotriene modifiers in the treatment of asthma and discusses the benefit of using methylprednisolone in patients with adult respiratory distress syndrome, among many other advances in internal medicine.

Entities:  

Mesh:

Year:  2000        PMID: 11068074      PMCID: PMC2805898          DOI: 10.1016/s0188-4409(00)00076-x

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  147 in total

1.  Evidence-based medicine.

Authors:  F López-Jiménez; G A Lamas
Journal:  Arch Med Res       Date:  1999 Mar-Apr       Impact factor: 2.235

2.  A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. The THESEE Study Group. Tinzaparine ou Heparine Standard: Evaluations dans l'Embolie Pulmonaire.

Authors:  G Simonneau; H Sors; B Charbonnier; Y Page; J P Laaban; R Azarian; M Laurent; J L Hirsch; E Ferrari; J L Bosson; D Mottier; B Beau
Journal:  N Engl J Med       Date:  1997-09-04       Impact factor: 91.245

3.  An updated coronary risk profile. A statement for health professionals.

Authors:  K M Anderson; P W Wilson; P M Odell; W B Kannel
Journal:  Circulation       Date:  1991-01       Impact factor: 29.690

4.  A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy.

Authors:  A Freifeld; D Marchigiani; T Walsh; S Chanock; L Lewis; J Hiemenz; S Hiemenz; J E Hicks; V Gill; S M Steinberg; P A Pizzo
Journal:  N Engl J Med       Date:  1999-07-29       Impact factor: 91.245

5.  Treatment of early rheumatoid arthritis with minocycline or placebo: results of a randomized, double-blind, placebo-controlled trial.

Authors:  J R O'Dell; C E Haire; W Palmer; W Drymalski; S Wees; K Blakely; M Churchill; P J Eckhoff; A Weaver; D Doud; N Erikson; F Dietz; R Olson; P Maloley; L W Klassen; G F Moore
Journal:  Arthritis Rheum       Date:  1997-05

6.  Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review.

Authors:  W D Weaver; R J Simes; A Betriu; C L Grines; F Zijlstra; E Garcia; L Grinfeld; R J Gibbons; E E Ribeiro; M A DeWood; F Ribichini
Journal:  JAMA       Date:  1997-12-17       Impact factor: 56.272

7.  1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction).

Authors:  T J Ryan; E M Antman; N H Brooks; R M Califf; L D Hillis; L F Hiratzka; E Rapaport; B Riegel; R O Russell; E E Smith; W D Weaver; R J Gibbons; J S Alpert; K A Eagle; T J Gardner; A Garson; G Gregoratos; T J Ryan; S C Smith
Journal:  J Am Coll Cardiol       Date:  1999-09       Impact factor: 24.094

8.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.

Authors: 
Journal:  Lancet       Date:  1996-11-16       Impact factor: 79.321

9.  A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators.

Authors:  M B Leon; D S Baim; J J Popma; P C Gordon; D E Cutlip; K K Ho; A Giambartolomei; D J Diver; D M Lasorda; D O Williams; S J Pocock; R E Kuntz
Journal:  N Engl J Med       Date:  1998-12-03       Impact factor: 91.245

10.  Effects of aminoguanidine in preventing experimental diabetic nephropathy are related to the duration of treatment.

Authors:  T Soulis; M E Cooper; D Vranes; R Bucala; G Jerums
Journal:  Kidney Int       Date:  1996-08       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.